Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jul 1;45(4):E1.
doi: 10.1503/jpn.2045301.

Clozapine and COVID-19

Affiliations
Comment

Clozapine and COVID-19

Gary Remington et al. J Psychiatry Neurosci. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

G. Remington has received clinical, research and advisory board support from HLS Therapeutics, consultant fees from Mitsubishi-Tanabe Pharma Corporation, and research support from the University of Toronto, Canadian Institutes of Health Research (CIHR) and Research Hospital Fund–Canada Foundation for Innovation (RHF-CFI). No other competing interests were declared.

Comment in

  • Clozapine and COVID-19: The authors respond.
    Siskind D, Honer WG, Clark S, Correll CU, Hasan A, Howes O, Kane JM, Kelly DL, Laitman R, Lee J, MacCabe JH, Myles N, Nielsen J, Schulte PF, Taylor D, Verdoux H, Wheeler A, Freudenreich O. Siskind D, et al. J Psychiatry Neurosci. 2020 Jul 1;45(4):E1-E2. doi: 10.1503/jpn.2045302. J Psychiatry Neurosci. 2020. PMID: 32584530 Free PMC article. No abstract available.

Comment on

  • J Psychiatry Neurosci. 2020 Apr 03;45(4):200061.
  • Consensus statement on the use of clozapine during the COVID-19 pandemic.
    Siskind D, Honer WG, Clark S, Correll CU, Hasan A, Howes O, Kane JM, Kelly DL, Laitman R, Lee J, MacCabe JH, Myles N, Nielsen J, Schulte PF, Taylor D, Verdoux H, Wheeler A, Freudenreich O. Siskind D, et al. J Psychiatry Neurosci. 2020 May 1;45(3):222-223. doi: 10.1503/jpn.200061. Epub 2020 Apr 3. J Psychiatry Neurosci. 2020. PMID: 32297722 Free PMC article. No abstract available.

References

    1. Siskind D, Honer WG, Clark S, et al. Consensus statement on the use of clozapine during the COVID-19 pandemic. J Psychiatry Neurosci. 2020;45 200061. - PMC - PubMed
    1. Druss BG. Addressing the COVID-19 Pandemic in populations with serious mental illness. JAMA Psychiatry. 2020 doi: 10.1001/jamapsychiatry.2020.0894. - DOI - PubMed
    1. Myles N, Myles H, Xia S, et al. Meta-analysis examining the epidemiology of clozapine-associated neutropenia. Acta Psychiatr Scand. 2018;138:101–9. - PubMed
    1. Andres E, Villalba NL, Zulfiqar AA, et al. State of art of diosyncratic drug-induced neutropenia or agranulocytosis, with a focus on biotherapies. J Clin Med. 2019;8:1351. - PMC - PubMed
    1. Whiskey E, Dzahini O, Ramsay R, et al. Need to bleed? Clozapine haematological monitoring approaches a time for change. Int Clin Psychopharmacol. 2019;34:264–8. - PubMed